Top Institutions in Precision Medicine and Companion Diagnostics
Institutions leading in this area typically have integrated programs combining translational research, clinical trials, pathology expertise, and regulatory science to develop and validate biomarkers and companion diagnostics, alongside strong collaborations with industry and regulatory bodies to facilitate clinical adoption.
-
#1
Memorial Sloan Kettering Cancer Center
New York, NY
MSKCC is a global leader in precision oncology with extensive expertise in biomarker discovery, clinical validation, and integration of companion diagnostics into routine cancer care, supported by its robust molecular pathology and genomics programs.
Key Differentiators
- Precision Oncology
- Molecular Pathology
- Companion Diagnostics
-
#2
Dana-Farber Cancer Institute
Boston, MA
Dana-Farber integrates cutting-edge genomic research with clinical trials to develop and implement companion diagnostics, emphasizing rapid translation of biomarker discoveries into clinical practice.
Key Differentiators
- Cancer Genomics
- Translational Medicine
- Companion Diagnostics
-
#3
Johns Hopkins Medicine
Baltimore, MD
Johns Hopkins has a strong history in biomarker research and clinical assay development, with integrated pathology and oncology programs facilitating the translation of companion diagnostics into clinical workflows.
Key Differentiators
- Molecular Pathology
- Precision Medicine
- Diagnostic Development
-
#4
University of California, San Francisco (UCSF) Medical Center
San Francisco, CA
UCSF combines strong clinical genomics infrastructure with translational research programs focused on biomarker validation and companion diagnostic implementation in diverse clinical settings.
Key Differentiators
- Precision Oncology
- Molecular Diagnostics
- Clinical Genomics
-
#5
Mayo Clinic
Rochester, MN
Mayo Clinic has extensive experience in developing and validating clinical-grade molecular assays and integrating companion diagnostics into multidisciplinary care pathways across its health system.
Key Differentiators
- Molecular Diagnostics
- Pathology
- Precision Medicine
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Newsletters
Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.
About the Author(s)
Helen Bristow
Combining my dual backgrounds in science and communications to bring you compelling content in your speciality.
